Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL ® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with

Posted from: this blog via Microsoft Power Automate.